NEW YORK , May 26, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zenas BioPharma, Inc. (NASDAQ: ZBIO) pursuant and/or traceable to the registration statement and prospectus (collectively, the "Registration Statement") issued in connection with Zenas BioPharma's September 2024 initial public offering ("IPO" or the "Offering"), of the important June 16, 2025 lead plaintiff deadline in the securities class action first filed by the Firm. So What: If you purchased Zenas BioPharma securities you may be entitled to compensation without payment of any out of pocket fees or costs …

Insider selling at Palantir Technologies (NASDAQ: PLTR) surged dramatically last week, with company executives offloading over $124 million in stock across just two trading days.

Evaxion has demonstrated impressive in-house capabilities for discovering and developing vaccine candidates for both infectious diseases and oncology indications. Partnership with MSD, albeit heavily backloaded, provides considerable validation of Evaxion's value. A potential option exercise by MSD expected later this year would bring in up to $10M. EVAX guides a cash runway into mid-2026, which could be extended into 2027 if MSD exercises options for both partnered candidates (not accounting for potential further business developments).

Palantir (NASDAQ:PLTR) has been a top-performing stock after a few slow years.

KGC stock surges 39% in three months on strong earnings, rising gold prices and solid project pipeline ??? analysts see more upside ahead.

In the last several years, YouTube has become an increasingly formidable competitor to streaming services and entertainment studios, providing videos from amateur and professional creators, as well as livestreaming major events and NFL games.

Traeger is a high-risk, high-reward turnaround play, now trading at deep value after a 55% share price drop due to tariff and economic uncertainty. Despite modest revenue declines, profitability metrics have improved, with better margins and cost controls offsetting lower average selling prices. Management is actively mitigating tariff exposure by shifting production, raising prices, and streamlining operations, but near-term volatility remains high.

Apple Chief Executive Tim Cook can't seem to catch a break.

Gold pulls back after Trump delays EU tariffs, but safe-haven demand and fiscal fears keep the gold price outlook bullish above $3,310.

NEW YORK , May 26, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) between October 31, 2022 and August 2, 2024, both dates inclusive (the "Class Period"), of the important May 27, 2025 lead plaintiff deadline. So what: If you purchased Actinium securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

NEW YORK, NY / ACCESS Newswire / May 26, 2025 / If you suffered a loss on your Civitas Resources, Inc. (NYSE:CIVI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/civitas-resources-lawsuit-submission-form?prid=150214&wire=1&utm_campaign=12 or contact Joseph E. Levi, Esq.

VANCOUVER, Canada--(BUSINESS WIRE)--Newmont Corporation (NYSE: NEM, TSX: NGT, ASX: NEM, PNGX: NEM) (“Newmont”) has announced an CAD $8 million community investment to benefit the Tahltan Nation as part of its celebration of the tenth anniversary of the Red Chris Mine. The investment, which will benefit the communities of Telegraph Creek, Dease Lake and Iskut, was announced during a special event on Saturday, May 24th in Dease Lake, British Columbia held in commemoration of the successful co-man.

NEW YORK, NY / ACCESS Newswire / May 26, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/viatris-inc-lawsuit-submission-form-2?prid=150212&wire=1&utm_campaign=29 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 26, 2025 / If you suffered a loss on your Compass Group Diversified Holdings, LLC (NYSE:CODI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/compass-diversified-lawsuit-submission-form?prid=150213&wire=1&utm_campaign=15 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 26, 2025 / If you suffered a loss on your BigBear.ai Holdings, Inc. (NYSE:BBAI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/bigbear-ai-holdings-inc-lawsuit-submission-form?prid=150211&wire=1&utm_campaign=27 or contact Joseph E. Levi, Esq.

NNN REIT offers stability, high occupancy, and 35 years of dividend growth, making it ideal for income-focused investors seeking passive real estate exposure. The triple net lease structure minimizes landlord responsibilities, while disciplined acquisitions and conservative debt management support long-term resilience. NNN trades at attractive valuations versus peers, with a 5.64% dividend yield and strong coverage, providing both income and potential capital appreciation.

Company Announcement COPENHAGEN, Denmark; May 26, 2025 – Genmab A/S (Nasdaq: GMAB). On March 25, 2025, Genmab announced the initiation of a share buy-back program to repurchase up to 2.2 million shares to reduce capital and to honor our commitments under the Restricted Stock Unit program.

Kyndryl is well-positioned for $1 billion adjusted free cash flow by 2028, driven by cloud, AI, and modernization services demand. The company's leadership in cloud modernization, especially for financial services, and growing consultancy revenues support my bullish outlook. Despite a recent revenue decline, KD's low EV/EBITDA and strong fundamentals make it an attractive, undervalued buy versus peers.

NEW YORK, May 26, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Elevance Health, Inc. (NYSE: ELV) between April 18, 2024 and October 16, 2024, both dates inclusive (the “Class Period”), of the important July 11, 2025 lead plaintiff deadline.

Sensodyne launches new premium Clinical White toothpaste to brighten Canadians' smiles in time for National Smile Day. Sensodyne launches new premium Clinical White toothpaste to brighten Canadians' smiles in time for National Smile Day.